Streptavidin-Displaying

Po-Chih Wu, Shi-Yu Tseng, Shao-Yi Hou, Po-Shiuan Hsieh, Wen-Zhi Lin, Chin-Mao Hung

Abstract read

In one paragraph

Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Po-Chih WuGraduate Institute of Medical Sciences, College of Medicine, National Defense Medical University, Taipei City 114201, Taiwan.

Shi-Yu TsengGraduate Institute of Microbiology and Immunology, College of Biomedical Sciences, National Defense Medical University, Taipei City 114201, Taiwan.

Shao-Yi HouDepartment of Chemical Engineering and Biotechnology, National Taipei University of Technology, Taipei City 106344, Taiwan.ORCID 0000-0002-2833-8252

Po-Shiuan HsiehGraduate Institute of Medical Sciences, College of Medicine, National Defense Medical University, Taipei City 114201, Taiwan.ORCID 0000-0002-3402-9851

Wen-Zhi LinGraduate Institute of Microbiology and Immunology, College of Biomedical Sciences, National Defense Medical University, Taipei City 114201, Taiwan.

Chin-Mao HungGraduate Institute of Medical Sciences, College of Medicine, National Defense Medical University, Taipei City 114201, Taiwan.

Funding

Ministry of National Defense MND-MAB-D-114192 and MND-MAB-D-115205National Taipei University of Technology NTUT-CHGH-112-06

6 · The paper itself

Abstract

Enhancing the visual detection sensitivity of point-of-care (POC) optical sensors without resorting to complex, multistep chemical or enzymatic signal amplification remains a major challenge in sensor nanotechnology. Here, we present a multifunctional bio-nanostructured hybrid platform that integrates engineered

Indexed as

Biosensing TechniquesColorimetryEscherichia coliGoldMetal NanoparticlesStreptavidinCOVID-19HumansLimit of DetectionSARS-CoV-2GoldStreptavidinbio-nanostructured hybridscolorimetric biosensingmultifunctional platformpathogen detectionplasmonic couplingpoint-of-care testing

Identifiers

PMID42817544

DOI10.3390/s26185965

PMCPMC13611320

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.